• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASENSUS SURGICAL, INC. SENHANCE; SENHANCE SURGICAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASENSUS SURGICAL, INC. SENHANCE; SENHANCE SURGICAL SYSTEM Back to Search Results
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problem Rectal Anastomotic Leakage (4482)
Event Date 10/20/2020
Event Type  Injury  
Event Description
The complainant, (b)(6), reported that on day 6, there was an anastomotic leakage detected, then clinically and digitally confirmed.Patient was administered antibiotic therapy (metronidazole-500 mg 3x daily; cefuroxime-1 g 3x daily) and had a prolonged hospital stay but recovered for a (b)(6) 2020 date of resolution.It was reported that causality to the senhance surgical system was possible.This event did not occur within the u.S.This event occurred in (b)(6) hospital in lithuania.Additionally, this event occurred on (b)(6) 2020, and asensus surgical was internally made aware on 10-august-2023.
 
Event Description
The complainant, (b)(6), reported that on day 6, there was an anastomotic leakage detected, then clinically and digitally confirmed.Patient was administered antibiotic therapy (metronidazole-500 mg 3x daily; cefuroxime-1 g 3x daily) and had a prolonged hospital stay but recovered for a 04-november-2020 date of resolution.It was reported that causality to the senhance surgical system was possible.This event did not occur within the u.S.This event occurred in (b)(6) hospital in lithuania.Additionally, this event occurred on 20-october-2020, and asensus surgical was internally made aware on 10-august-2023.
 
Manufacturer Narrative
Based on the complaint details ((b)(4)), the patient experienced anastomotic leakage, was successfully treated with antibiotics (metronidazole 500mg 3x daily, cefuroxime 1g 3x daily), and had a prolonged hospital stay but recovered for a 04-november-2020 date of resolution.This event did not occur within the united states.This event occurred at (b)(6) hospital in lithuania.The event occurred on 20-october-2020, and asensus surgical was made aware on 10-august-2023.According to the investigation, further responses from surgeon interviews indicated that the anastomotic leakage event was not related to the senhance surgical system, but rather considered to be a normal surgical complication unrelated to the robot.Furthermore, no malfunction of the senhance system was reported and no failures were identified.The risk posed by this event was evaluated through a health hazard evaluation (b)(4) and a corrective action preventative action plan (capa-000048) has been opened to manage the unsuitable timeliness of the receipt and management of this reported event.Therefore, asensus surgical is reporting this followup for completeness to the initial mdr report submitted on 19-september-2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SENHANCE
Type of Device
SENHANCE SURGICAL SYSTEM
Manufacturer (Section D)
ASENSUS SURGICAL, INC.
1 tw alexander dr
suite 160
durham NC 27703 7035
Manufacturer (Section G)
ASENSUS SURGICAL ITALIA, S.R.L.
viale dell'innovazione, 3
milan, lombardy 20126
IT   20126
Manufacturer Contact
casey hinckley
1 tw alexander dr
suite 160
durham, NC 27703-7035
9197658400
MDR Report Key17774502
MDR Text Key323743073
Report Number3007593944-2023-00004
Device Sequence Number1
Product Code NAY
Combination Product (y/n)N
Reporter Country CodeLH
PMA/PMN Number
K171120
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/10/2023
Initial Date FDA Received09/19/2023
Supplement Dates Manufacturer Received08/10/2023
Supplement Dates FDA Received10/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-